$LLY Next-Generation Drug Pumps Profits

Trader see the trade of the week inside... You receive this email, because you signed up to get email from YellowTunnel newsletter on 06/30/21.  If you no longer wish to receive any emails from YellowTunnel, please use the "Unsubscribe" link towards the bottom of this email. [Image] August 13th, 2023 | Issue 195   Hello Trader Recently, I had the pleasure of going to the cinema to watch Christopher Nolan's latest masterpiece, "Oppenheimer." In a world where science and war collide, where the brilliance of human ingenuity sparks both marvel and apprehension, I found myself utterly captivated by the film. As the screen came alive with beautiful vistas and powerful performances, the story not only tracked the birth of the atomic bomb and its impact, but also the incredibly complicated and unique historical figure behind it. While three hours long, the film flew by from the first note and never lost my attention as it grappled with much more than the science at hand; politics, war, guilt, consequences, innovation, and many other themes pollinated the incredibly beautiful and complex film - which felt eerily poignant for our current time.  The movie opens with a profound quote from Greek mythology, invoking the legend of Prometheus and the enduring repercussions of his audacious gift to humanity.  Prometheus, the titan who bestowed fire upon mortals, suffered an eternal punishment for his audacious act. Chained to a rock, his mind was twisted by the contradictions and became a symbol for the complexity of innovation and its unintended outcomes. Nolan's film, "Oppenheimer," brilliantly introduces this mythic tale as the launching point for this tale of the creation of the atomic bomb and the man behind it. The sweeping narrative unfolds against the backdrop of war, rising geopolitical tensions (specifically with Russia,) and key breakthroughs in the STEM field, mirroring our current world in remarkable ways. [AI-Powered Stock GPS: Put Yourself on The Fast Track to Trading Success... Click Here]( As the film's narrative unfolded, a striking realization surfaced: the evolution of Artificial Intelligence closely mirrors the critical juncture when the atom was split, igniting an arms race that forever changed the world. Today, A.I., much like the atomic bomb of the past, has ignited a race, albeit in the realms of technology and innovation. It's an intoxicating chase where titans like Microsoft and entire national forces are locked in a contest to harness AI's monumental potential. Yet, within this rush lies an intricate paradox—A.I.'s transformative prowess carries unknown consequences, its sheer power echoing the duality of the atomic bomb's promise and peril. The complexity of Oppenheimer's character echoes the possibilities within the A.I. landscape, those creating it, and even those harnessing it.  We stand on the precipice of our own Prometheus moment, as A.I. ushers in a new era of possibilities. The echoes of history remind us of the atomic bomb's dual nature: a marvel of science and a harbinger of destruction. Similarly, AI's ascent brings both unprecedented financial opportunities and an inherent risk to the fabric of our trading landscape.  In the realm of finance, A.I. presents a parallel that cannot be ignored. Just as Oppenheimer's discoveries reshaped the world, A.I. is poised to reshape trading and investing. The gap between hedge funds and retail traders may be stretched to new dimensions, or AI could bridge that divide, offering opportunities to all. At YellowTunnel, our mission is clear: to equip both novice and experienced traders with the tools needed to navigate the ever-evolving, tech-driven financial universe.  As Prometheus wrestled with the consequences of his gift to man and Oppenheimer grappled with the forces he unleashed, we find ourselves at a pivotal juncture, poised to shape the future of finance through the lens of artificial intelligence. While "Oppenheimer" left me awe-struck and contemplative, our journey into the world of finance with the aid of A.I. look to be one that runs on similar tracks of exploration, innovation, and transformation. Welcome to a new era, where history meets finance, and where A.I. guides us toward a profitable future yet to be written. [Image] To great returns, [Image] Vlad Karpel YellowTunnel and Tradespoon Founder P.S. [Click here]( for access to the Power Trading Live Strategy Roundtable Recorded every Thursday.   TRADE IDEA OF THE WEEK $LLY Next-Generation Drug Pumps Profits In the realm of healthcare, where innovation merges with human well-being, a standout player has emerged in recent years, poised to tap into the ever-evolving landscape of medical advancements. Eli Lilly and Co., the trading symbol $LLY, is a pharmaceutical powerhouse that exemplifies the potential for growth within the healthcare sector. Eli Lilly and Company, known as Lilly, standouts within the healthcare sector, navigating the world of pharmaceuticals with a commitment to innovation and patient care. As market narratives intertwine with economic insights, a compelling opportunity arises for discerning investors to consider Lilly as a prime contender.  Lilly's recent analyst-upgrade showcases the growing confidence in its market performance. The report highlights the success of Lilly's Mounjaro treatment, with strong sales contributing to its upward trajectory. This achievement, coupled with Lilly's ongoing dedication to research and development, underscores its position as a frontrunner in healthcare innovation. Lilly's strategic prowess is further accentuated by its strong position in the obesity drug market. The company has reported substantial market cap increase, amounting to $60 billion, triggered by the anticipation of Lilly's obesity drug. This promising prospect adds weight to the idea that Lilly's commitment to addressing critical medical challenges is both visionary and potentially lucrative.  In a landscape where A.I. and technological advancements are transforming the healthcare landscape, Lilly's strategic moves have garnered attention. Its focus on next-generation drugs and innovative solutions aligns perfectly with the evolving healthcare trends. With Lilly's commitment to advancing patient care, its recent financial upgrade, and the healthcare sector's resilience, coupled with Lilly's innovation-focused approach, could provide stability and potential growth amidst market fluctuations.  Informed by insights from my A.I. as well as global trends and economic trajectories, now is the opportune time to embrace Lilly as an investment that aligns with our portfolio strategy. [Click here to read more about this week’s Power Trade pick…](     TRADE REVIEW Our Profit Accelerator Trader services (PAT services) have once again proven its value after closing the position we discussed from last week. In a recent move, we set our sights on Schlumberger Limited ($SLB) as a potential opportunity for our traders. The decision to highlight this stock was driven by the meticulous analysis of our PAT model, which detected promising indicators within the $SLB market landscape. On 7/31/23, I took the step to enter into a strategic position with $SLB.  What sets our paid services apart from their free counterparts is the invaluable inclusion of SMS notifications. This feature keeps you well-informed about crucial entry and exit points, ensuring that you're equipped to respond to market fluctuations in a timely and advantageous manner. We understand that the market waits for no one, and our commitment to enhancing your trading experience drives us to provide the tools necessary for nimble decision-making.  For those eager to revisit the intricate details of this trade, we've got you covered. The recording of our live trading room session held on that Tuesday encapsulates the essence of our strategy, the rationale behind our actions, and the unfolding market dynamics. To access this valuable resource, simply follow the link provided below:  [Yellow Tunnel Live Trading Room Recordings](  As we stride forward, fueled by our dedication to exploring and capitalizing on potential trades, our mission remains unwavering: to deliver meaningful insights and timely updates that empower you to make informed trading decisions. Keep your connection strong with us, as we promise more trade opportunities, comprehensive analysis, and unwavering support in your journey toward enhanced trading profitability. [Click here to watch…](     (Advertisement) AI-Powered Stock GPS: Put Yourself on The Fast Track to Trading Success… Imagine having your own “Stock Trading GPS” carefully guiding you through the unexpected twists and turns of the market.  An advanced GPS that turns the threats of bank failures, global conflicts, and rising interest rates into unique profit opportunities! [Click Here To Learn More]( (A portion of Yellow Tunnel sales will go to directly help the Ukrainian people)     CURRENT TRADING LANDSCAPE The past week brought a mixture of results, with a particular focus on the Producer Price report that pointed to a rising trend in prices. This development caused the S&P and Nasdaq to venture into negative territory for the week, while the Dow managed to secure modest gains. This market movement occurs as investors grapple with the aftermath of the latest CPI inflation data, evaluating its impact on the broader economy and its implications for the Federal Reserve's rate-setting strategy. Source: Barchart.com In the midst of an economic atmosphere marked by low probabilities of recession and a declining US Dollar Index ($DXY), market observers are maintaining a cautiously neutral stance towards the path that lies ahead. Following a shift in sentiment during the mid-summer period, expectations of heightened volatility persist as we approach the latter months of the year. Despite an optimistic outlook, experts foresee a potential upper boundary for a SPY rally within the range of $450 to $470. Additionally, they identify short-term support levels within the 400-430 range for the upcoming months. For reference, the SPY Seasonal Chart is shown below: Following the latest inflation data, the Federal Reserve will be focused on one pivotal question: whether the pace of economic growth is cooling sufficiently to steer price growth back towards the central bank's targeted annual rate of 2%. The recent wholesale inflation data indicates a rebound in July, with the producer-price index (PPI) witnessing a 0.3% rise. Consequently, the 10-year Treasury yield surged to 4.153%. This uptick in long-term yields led to a decline in the value of future profits, weighing down on growth-oriented technology stocks.  Conversely, the University of Michigan's preliminary August numbers reveal a drop in inflation expectations for the year, settling at 3.3%. This reading comes on the heels of the PPI report and follows a cooler-than-anticipated consumer-price index (CPI) reading on Thursday. Interestingly, consumer sentiment exhibited a slight decline even as inflation expectations saw a minor decrease. The University of Michigan's consumer sentiment index dipped to 71.2 in the first half of August, down from 71.6 in July. This reading was slightly below the anticipated figure of 71.3... [Click here to read more…](   SECTOR SPOTLIGHT After the latest inflation data, one sector looks to benefit tremendously as it consistently stands as a pillar of global well-being. Its influence resonates through not only the financial world but reaches each individual, reflecting both the essence of healthcare and the potential for financial growth. As market narratives intertwine with economic insights, a strategic opportunity within this sector has presented itself - specifically with one symbol. The S&P 500 Healthcare Select Sector SPDR Fund (XLV) is an ETF that encapsulates significant healthcare entities, offering a window into the vitality of the healthcare sector. Amidst the latest market shifts, the healthcare sector remains a vital cornerstone with the potential to spark the interest of shrewd investors.  My latest A.I.-generated reports have illuminated healthcare as a domain on the brink of transformation. In the midst of discussions about AI stocks, economic trajectories, and market forecasts, the spotlight now centers on XLV as a captivating opportunity. As we delve into AI trends and global economic indicators, a picture emerges that signals a potentially propitious moment to explore the healthcare sector. The recent trading landscape has propelled XLV into prominence as the symbol nears its 52-week high with some ways to go, as well as the history to top previous highs. Fueled by a great fundamental trend, the healthcare sector seems poised for new horizons. And as I scan the healthcare sector, there is one symbol in particular that should benefit from the forecasted XLV pop. [Click here to continue reading…](   NOTE: We encourage all subscribers [to view the instructional videos]( on how to use your membership best and invite our members to participate in live weekly strategy roundtable workshops that are also archived for your convenience so that they can be viewed at a later time.   [How To Trade a Bear Market Strategy](  With the unpredictable nature of the market and the uncertainty ahead of us, I can’t emphasize enough how vital it is for our readers and members of the Yellow Tunnel community to keep referring to our Live Trading Room so as to maintain a close tie of how our I and my AI platform is navigating us in and out of select trades. [It’s FREE and I highly encourage everyone to sign up for the Live Trading Room and keep checking in throughout the trading day.Â](  Every Monday and Wednesday, I highlight our best strategies and potential trading setups via the DISCORD server. It’s the future of bringing together a trading community’s total services, educational products, live chat venues, support, news, how-to tutorials, webinars, live-trading demonstrations, and tons of market analysis. It is incredibly interactive and full of crucial and timely information. Just go to: [(  I also want to emphasize to traders how vital a stop-loss discipline is to winning and being successful in an unforgiving market. We employ specific stop-loss instructions with every trade. The buy and sell programs controlled by high-frequency related algorithms can create great profits or cause sudden losses, so it is imperative to maintain an element of controlling risk with each trade. TRADING CONCEPTS - VIDEO Market Analysis To effectively trade in today's rapidly moving equity markets, active day traders and swing traders must stay ahead of market changes due to inflation, global uncertainty, politics, as well as innovations and technological changes used by hedge fund traders and proprietary trading firms. With traders like you in mind, we designed this intensive roundtable where you will deepen your understanding of all aspects of stock and options trading in today’s changing market. [Click here to watch the video...](   DISCLAIMER: Vlad and his team may have a financial interest in the picks as they trade many of the same equities and options they pick. Vlad Karpel and YellowTunnel (Company) is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. All investing strategies are made available to the general public on a regular basis. We do not provide personalized financial advice or investment recommendations. As an investor, you know that any kind of investment opportunity has its risks. There is no such thing as low-risk stocks and we recommend you invest wisely and that only risk capital should be used to trade. Investing in Stocks and Options is highly speculative. No representation is being made that the use of this strategy or any system or trading methodology will generate profits. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed here and on our website. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE SUCCESS: It should not be assumed that the methods, techniques, or indicators developed at YellowTunnel will be profitable or that they will not result in losses. Nor should it be assumed that future picks will be profitable or will equal past performance. All of the content on our website and in our email alerts is for informational purposes only and should not be construed as an offer, or solicitation of an offer, to buy or sell securities. Remember, you should always consult with a licensed securities professional before purchasing or selling securities of companies profiled or discussed on YellowTunnel.com. Performance results that are discussed above are from the Live Trading Room. Multiple YellowTunnel tools were used to achieve these results. Trade % Gain/Loss is calculated by dividing the $ Gain/Loss by the Max Risk, which is the posted Stop Loss for the trade. Yellow Tunnel’s performance data represents the average return on all trading recommendations from January 1, 2020, to today. *Win rate percentage reflects the average that Yellow Tunnel’s software helped me identify a profitable investment strategy.** Triple-digit returns are not typical and are not intended to reflect the likelihood of similar returns in the future. This email was sent to {EMAIL} by info@yellowtunnel.com. Questions or inquiries regarding the website and/or service may be submitted via email to i[nfo@yellowtunnel.com](mailto:Info@Yellowtunnel.com?subject=Questions%20or%20Inquires%20PTM%20Blog). You may also complete our [inquiry form located here](.  YellowTunnel LLC, 318 Half Day Rd., Suite #215, Buffalo Grove, Illinois 60089. Website: [](  Copyright © 2023 Yellow Tunnel LLC. All rights reserved.  If you want to unsubscribe from all or some of our emails please click this [link]( [Facebook]( [Twitter]( [Instagram](   In order to unsubscribe from this mailing list, please click [here](